SCHEMBL5464359

SCHEMBL5464359

CN(C)C(=O)c1ccc(-c2ccc(NC(=O)Nc3cccc(Br)c3)cc2-c2nnn[nH]2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 8/20 0.47
KIT P10721 6/20 0.47
FLT3 P36888 6/20 0.47
AURKA O14965 4/20 0.47
ROCK2 O75116 4/20 0.47
CSF1R P07333 4/20 0.47
FLT1 P17948 4/20 0.47
RPS6KB1 P23443 4/20 0.47
FLT4 P35916 4/20 0.47
RPS6KA3 P51812 4/20 0.47
ROCK1 Q13464 4/20 0.47
AURKB Q96GD4 4/20 0.47
PLK4 O00444 3/20 0.47
RPS6KA5 O75582 3/20 0.47
MAP4K4 O95819 3/20 0.47
LYN P07948 3/20 0.47
RET P07949 3/20 0.47
FGFR1 P11362 3/20 0.47
EPHA2 P29317 3/20 0.47
AXL P30530 3/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5464363 0.86 KDR (0.49) KDRKITFLT3AURKAROCK2
SCHEMBL1463312 0.86 KDR (0.48) KDRKITFLT3AURKAROCK2
SCHEMBL5476680 0.86 KDR (0.46) KDRKITFLT3AURKAROCK2
SCHEMBL5468764 0.85 CYP3A4 (0.39) KDRKITFLT3ROCK1AURKB
SCHEMBL5471398 0.83 TACR1 (0.43) KDRKITFLT3AURKACSF1R
SCHEMBL5474061 0.75 KDR (0.50) KDRKITFLT3AURKAROCK2
SCHEMBL1463540 0.75 GRIK1 (0.50) KDRKITFLT3AURKAROCK2
SCHEMBL5471433 0.74 KDR (0.52) KDRKITFLT3AURKAROCK2
SCHEMBL5950680 0.73 GRIK1 (0.68) GRIK1HTTMAPTKDM4EMEN1
SCHEMBL5950633 0.73 TRPV1 (0.37) KDRKITFLT3CSF1RFLT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070293553-A1 Diphenylurea Derivatives Useful As Potassium Channel Activators NEUROSEARCH A/S (DK) 2007-12-20 US claimed
US-20070293553-A1 Diphenylurea Derivatives Useful As Potassium Channel Activators NEUROSEARCH A/S (DK) 2007-12-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070293553-A1 Diphenylurea Derivatives Useful As Potassium Channel Activators KCNJ2, KCNH2, KCNH3 KDR 1142/4885KIT 1089/4885FLT3 2643/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.